BEAT
Q4 2026 EPS Estimate
$-0.09
Nov 12, 2026 · Reports after close
Revenue Estimate
$131,250
FY2029E EPS$0.35
FY2030E EPS$0.74

Analyst Sentiment

Wall St. Consensus
Buy
13 analysts·Moderate coverage
67
Score
9 Buy (69%)4 Hold (31%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
969%
Hold
431%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$2.00
+318.1%
Consensus
$2.00
+318.1%
Bull
$2.00
+318.1%
12-Month Target Range13 analysts
$2.00$2.00$2.00
Current $0.48Consensus
Current Price
$0.48
Upside to Consensus
$1.52

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+540.21%
EPS
FY2028
Rev+232.34%
EPS
FY2029
Rev+298.32%
EPS
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029EFY2030E
Revenue Avg$836,200$5M$18M$71M$127M
Low$631,416$3M$9M$35M$63M
High$1M$8M$25M$99M$177M
EBITDA Avg
Low
High
EBIT Avg
Low
High
Net Income Avg$-12M$-9M$-2M$12M$25M
Low$-13M$-10M$-7M$4M$9M
High$-11M$-9M$-1M$18M$38M
EPS Avg$-0.36$-0.28$-0.14$0.35$0.74
Low$-0.39$-0.29$-0.21$0.12$0.26
High$-0.32$-0.26$-0.03$0.53$1.13
Analysts (Rev / EPS)2 / 33 / 33 / 31 / 12 / 1
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028
Revenue Avg$241,800$387,200$751,500$1M$1M$2M$5M$5M
Low$161,200$276,571$507,259$688,496$903,482$1M$3M$4M
High$322,400$553,142$1M$1M$2M$3M$7M$7M
EBITDA Avg
Low
High
EBIT Avg
Low
High
Net Income Avg$-4M$-4M$-4M$-4M$-4M$-3M$-934,115$-691,351
Low$-5M$-5M$-6M$-5M$-5M$-5M$-1M$-1M
High$-4M$-4M$-2M$-2M$-2M$-2M$-539,447$-399,252
EPS Avg$-0.08$-0.08$-0.07$-0.07$-0.07$-0.06$-0.02$-0.01
Low$-0.09$-0.09$-0.11$-0.10$-0.10$-0.09$-0.03$-0.02
High$-0.07$-0.07$-0.04$-0.04$-0.04$-0.03$-0.01$-0.01
Analysts (Rev / EPS)2 / 33 / 41 / 11 / 11 / 11 / 11 / 21 / 2

Earnings Surprises

Recent Analyst Actions

Jul 14, 2026Maxim Group
HeartBeam initiated with a Buy at Maxim
Target:$2.00
+246.1%from $0.58
Dec 11, 2025H.C. Wainwright
Heartbeam Inc. (BEAT) PT Raised to $5.50 at H.C. Wainwright
Target:$5.50
+188.6%from $1.91
Dec 10, 2025UBS
HeartBeam price target raised to $5.50 from $2.50 at H.C. Wainwright
Target:$5.50
+259.5%from $1.53
Dec 8, 2025H.C. Wainwright
HeartBeam initiated with a Buy at H.C. Wainwright
Target:$2.50
+242.5%from $0.73
Oct 31, 2025Roth Capital
HeartBeam initiated with a Buy at Roth Capital
Target:$4.00
+148.4%from $1.61
Dec 2, 2022Industrial Alliance Securities
Alliance Global Partners Initiates Coverage On HeartBeam with Buy Rating, Announces Price Target of $10
Target:$10.00
+132.2%from $4.31
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.